DIN 02451379 — ORKAMBI 125 MG; 200 MG
ORKAMBI is a tablet of Lumacaftor / Ivacaftor marketed by VERTEX PHARMACEUTICALS (CANADA) INCORPORATED. The full Lumacaftor / Ivacaftor monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02451379
- Brand name
- ORKAMBI
- Active ingredient
- Lumacaftor / Ivacaftor
- Strength
- 125 MG; 200 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- VERTEX PHARMACEUTICALS (CANADA) INCORPORATED
- Health Canada status
- MARKETED
- Drug class
- Cystic fibrosis transmembrane conductance regulator (CFTR) corrector and potentiator combination
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Lumacaftor / Ivacaftor products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02463040 | ORKAMBI | 100 MG; 125 MG | TABLET | VERTEX PHARMACEUTICALS (CANADA) INCORPORATED | MARKETED |
| 02483831 | ORKAMBI | 125 MG; 100 MG | GRANULES | VERTEX PHARMACEUTICALS (CANADA) INCORPORATED | MARKETED |
| 02483858 | ORKAMBI | 150 MG; 188 MG | GRANULES | VERTEX PHARMACEUTICALS (CANADA) INCORPORATED | MARKETED |
| 02537087 | ORKAMBI | 75 MG; 94 MG | GRANULES | VERTEX PHARMACEUTICALS (CANADA) INCORPORATED | MARKETED |